Category: Joint ventures/collaborations
-
Sanofi, Biotech Partner on RNA Covid-19 Vaccine
Drug maker Sanofi and biotechnology company Translate Bio are creating a new vaccine to protect against the virus causing Covid-19 infections
-
Business-Academic A.I. Research Network Formed
Two companies, including Microsoft Corp., and several research universities plan to study artificial intelligence for digitally transforming government and business.
-
Smart Watches Enlisted to Detect Viral Outbreaks
A research institute is asking people with smart watches and activity trackers to donate their data to find early signs of viral disease outbreaks, like Covid-19.
-
Consortium to Find Neutralizing Viral Antibodies
A coalition of business and academic labs is creating a process to quickly identify antibodies in blood samples that neutralize viruses like SARS-CoV-2.
-
New Venture Formed to Discover Neuro Therapies
Two drug discovery companies are forming a joint venture to discover treatments for neurological conditions based on cannabinoid-like compounds.
-
WHO Beginning Covid-19 Therapy Trial
World Health Organization is organizing an international clinical trial to test four treatments for the novel coronavirus, or Covid-19, pandemic.
-
Trial Testing Arthritis Drug as Covid-19 Treatment
A clinical trial is enrolling patients with severe novel coronavirus infections to test a synthetic antibody now approved to treat rheumatoid arthritis.
-
Commentary – Biotech, Trump’s Latest Casino
If you thought the Trump administration couldn’t bungle any worse its response to the coronavirus pandemic, think again.
-
Lilly, Biotech, NIH to Develop Covid-19 Antibodies
Drug maker Eli Lilly and Co., a biotechnology company, and an agency of NIH are collaborating on antibodies for novel coronavirus vaccines and therapies.
-
Engineered Viruses Deployed to Treat Gut Infections
Academic and industry researchers created gene-editing viruses that in lab cultures and mice killed bacteria causing often deadly intestinal infections.